Navigation Links
Operations research promises continued gains for HIV treatment in resource-limited countries
Date:8/22/2008

NEW YORK (Aug. 22, 2008) -- In the past 10 years, the global campaign to expand treatment for millions of people with AIDS living in resource-limited countries, especially in sub-Saharan Africa, has gained substantial commitments in public and private financing, and has made major strides in making treatment available to those who need it. A new collaborative study by researchers at Weill Cornell Medical College and the Clinton Foundation HIV/AIDS Initiative explores how to combine engineering science with medical care to guarantee the long-term success of these treatment programs.

In an article published online this month in the BMC Health Services Research journal, the researchers show how the use of sophisticated mathematical modeling approaches used in the field of operations research can help maximize the efficient use of limited resources, notably antiretroviral drugs and medical personnel.

"Operations research offers a powerful set of tools that have been used successfully in everything from World War II to Wal-Mart-style logistics planning. These tools ought to be used to increase the success of existing programs and to help expand access to HIV care and treatment in resource-limited countries," says lead author Dr. Wei Xiong, instructor in public health at Weill Cornell Medical College. "For example, operations research could help with the planning of a national drug distribution system, or with predicting the demand for services at local clinics and the best ways to staff them."

"To date, HIV treatment scale-up has appropriately focused first on policy-level issues, such as program initiation and costs, and secondarily on operational-level issues," adds co-investigator Dr. Nathaniel Hupert, associate professor of public health at Weill Cornell Medical College and associate attending physician at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "Now that many programs are in place, the potential gains from
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. STEN Corporation Reports 2008 Third-Quarter Revenue of $5 Million and Improved Results From Operations
2. Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year
3. Stecher Named President of Conseco Insurance Group; Bostick to Lead Integrated IT and Operations Group at Conseco
4. American Media, Inc. Provides Dial-In Information for July 30 Call With Noteholders of American Media Operations, Inc. Subsidiary
5. Cardica Names Frederick Bauer Vice President of Operations
6. Ambulatory Services of America, Inc. Announces the Acquisition of Dialysis Operations in St. Louis, Missouri
7. Dr. Howard Epstein Joins Blue Cross as Medical Director for Commercial Operations and Clinical Design
8. SCAN Health Plan Arizona and SCAN Long Term Care Appoints Thomas Lescault President of Arizona Operations
9. Rioja Hospital Uses TIBCO Software to Improve Customer Care and Streamline Operations
10. Cantel Medical to Relocate Dutch Manufacturing Operations to the United States to Achieve Operating Savings
11. WHO Creates New Surgical Tool to Make Operations Safer Everywhere
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Are angry women more like men? 2
...nce,Commissioner Joel Ario today announced that th...ublic informational hearings across the state to,h...t how the proposed,consolidation of Highmark Inc. ...n Harrisburg,and July 15 in Philadelphia. Each inf...
...cted Officials Not to Privatize,Veterans, Health C...of Government Employees today launched a nationwid...l, mandatory funding for the Department of,Veteran...file veteran and a ranking member of the,Senate Ar...
...ch . , Montreal, May 12, 2008 Losing a limb can...tional and physical pain can linger for years. To ...imb syndrome, Universit de Montral graduate studen...es retain the memory of pain after losing a limb, ...
... cancers that affect tissues such as muscle, fat, ...n Milan, Italy on 13-14 May to discuss the latest ...ntial new avenues for therapy. , The 2nd Symposiu...netics of sarcomas, on understanding how drug resi...
...d to have committed patent and ...12 Mannatech,Incorporated (Nasdaq: MTEX ) a lead...and skin care solutions, today announced that a fe...ademark relating to Ambrotose(R)., The jury found...
... consumers on indoor air quality, ANN ARBOR, Mich... the Environmental Protection Agency (EPA), and DU...unity to educate consumers on the,importance of cl...0, and according to the American Lung Association,...
Other Medicine News:Health News:Insurance Department to Hold Statewide Meetings on Proposed Consolidation of Independence Blue Cross, Highmark 2Health News:AFGE Launches Nationwide Ad Campaign Aimed at Funding the VA 2Health News:2nd ESMO symposium on soft tissue carcinomas and GIST 2Health News:2nd ESMO symposium on soft tissue carcinomas and GIST 3Health News:Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products 2Health News:Jury Validates Key Mannatech Technology Patents Involving Its Ambrotose(R) Glyconutrient Products 3Health News:Asthma Awareness Month Spawns Healthy Advice 2
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 1Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 2Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 3Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 4Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 5Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 6Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 7Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 8Survey Shows At Risk Men Lacking In Prostate Cancer Knowledge 56594 9PDL BioPharma to Present at BioCentury Newsmakers Conference on September 16 2009 56592 1Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 1Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 2
...ith the continued aging of,the population and the ...f,the disease is crucial for risk assessment, test... with better drugs, once they are developed.,Four ...ion,s 2008,International Conference on Alzheimer,s... that goal of early detection by describing advanc...
...29 Bladder problems may,leave a mark on the brain...,contributing to disrupted sleep and problems with...active bladder, the involuntary bladder contractio...te, such mind-body,connections may be of more than...ust one organ, but here we see how an,abnormal org...
Other Medicine Technology:Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 2Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 3Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 4Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 5Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 6Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 7Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's 8Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention 2
...G-9200 is a Windows 2000 PC based EEG with high pe... and software. EEG-9200 provides high quality perf...in the sleep lab or EEG lab. Quality EEG recording...CU. Neurofax has high performance, high sensitivit...
...act is the first magnetic stimulator to offer the ... stimulation. It is designed to provide the simple...tic routine (at the same time, it may also help re...ons without moving away from your patient). , ,...
Fidelity IAB Intra-Aortic Balloon Catheter
...series is a new top-line range of digital pacemake...rillation (AF). Because the T-series combines digi...reatment of AF is taken one step further. Thanks t...ored continuously and extensively. This gives phys...
Medicine Products: